Evidence map›Paper›PMID 37013553›Full record

ArticleBMC complementary medicine and therapies2023

Bio-guided isolation of potential anti-inflammatory constituents of some endophytes isolated from the leaves of ground cherry (Physalis pruinosa L.) via ex-vivo and in-silico studies.

Asmaa Mahana, Hala M Hammoda, Mona M G Saad, Mohamed M Radwan, Mahmoud A ElSohly, Doaa A Ghareeb, Fathallah M Harraz, Eman Shawky

Open access · goldAbstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Asmaa MahanaDepartment of Pharmacognosy, Faculty of Pharmacy, Alexandria University, Egypt, 21521, Alexandria, Egypt.
Hala M HammodaDepartment of Pharmacognosy, Faculty of Pharmacy, Alexandria University, Egypt, 21521, Alexandria, Egypt.
Mona M G SaadDepartment of Pesticide Chemistry and Technology, Faculty of Agriculture, Alexandria University, 21545-El-Shatby, Alexandria, Egypt.
Mohamed M RadwanDepartment of Pharmacognosy, Faculty of Pharmacy, Alexandria University, Egypt, 21521, Alexandria, Egypt.
Mahmoud A ElSohlyNational Center for Natural Products Research, School of Pharmacy, University of Mississippi, MS, 38677, Mississippi, USA.
Doaa A GhareebBio-screening and Preclinical Trial Lab, Biochemistry Department, Faculty of Science, Alexandria University, Alexandria, Egypt.
Fathallah M HarrazDepartment of Pharmacognosy, Faculty of Pharmacy, Alexandria University, Egypt, 21521, Alexandria, Egypt.
Eman ShawkyDepartment of Pharmacognosy, Faculty of Pharmacy, Alexandria University, Egypt, 21521, Alexandria, Egypt. shawkyeman@yahoo.com.
Alexandria University · EGUniversity of Mississippi · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDue to the extensive potential of previously studied endophytes in addition to plants belonging to genus Physalis as a source of anti-inflammatory constituents, the present study aimed at isolation for the first time some endophytic fungi from the medicinal plant Physalis pruinosa.

methodsThe endophytic fungi were isolated from the fresh leaves of P. pruinosa then purified and identified by both morphological and molecular methods. Comparative evaluation of the cytotoxic and ex vivo anti-inflammatory activity in addition to gene expression of the three pro-inflammatory indicators (TNF-α, IL-1β and INF-γ) was performed in WBCs treated with lipopolysaccharide (LPS) for the identified endophytes, isolated compounds and the standard anti-inflammatory drug (piroxicam). For prediction of the binding mode of the top-scoring constituents-targets complexes, the Schrödinger Maestro 11.8 package (LLC, New York, NY) was employed in the docking study.

resultsA total of 50 endophytic fungal isolates were separated from P. pruinosa leaves. Selection of six representative isolates was performed for further bioactivity screening based on their morphological characters, which were then identified as Stemphylium simmonsii MN401378, Stemphylium sp. MT084051, Alternaria infectoria MT573465, Alternaria alternata MZ066724, Alternaria alternata MN615420 and Fusarium equiseti MK968015. It could be observed that A. alternata MN615420 extract was the most potent anti-inflammatory candidate with a significant downregulation of TNF-α. Moreover, six secondary metabolites, alternariol monomethyl ether (1), 3'-hydroxyalternariol monomethyl ether (2), alternariol (3), α-acetylorcinol (4), tenuazonic acid (5) and allo-tenuazonic acid (6) were isolated from the most potent candidate (A. alternata MN615420). Among the tested isolated compounds, 3'-hydroxyalternariol monomethyl ether showed the highest anti-inflammatory potential with the most considerable reductions in the level of INF-γ and IL-1β. Meanwhile, alternariol monomethyl ether was the most potent TNF-α inhibitor. The energy values for the protein (IL-1β, TNF-α and INF-γ)-ligand interaction for the best conformation of the isolated compounds were estimated using molecular docking analysis.

conclusionsThe results obtained suggested alternariol derivatives may serve as naturally occurring potent anti-inflammatory candidates. This study opens new avenues for the design and development of innovative anti-inflammatory drugs that specifically target INF-γ, IL-1β and INF-γ.

Indexed as

PhysalisTenuazonic AcidAlternariaAnti-Inflammatory AgentsEndophytesEthersLactonesMolecular Docking SimulationTumor Necrosis Factor-alphaalternariolalternariol monomethyl etherAnti-Inflammatory AgentsEthersLactonesTenuazonic AcidTumor Necrosis Factor-alphaAlternariaAnti-inflammatoryEndophytesEx vivoMolecular dockingPhysalis pruinosa

Identifiers

PMID37013553
PMCPMC10069101
OpenAlexW4362521226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.